This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Dam, M. Search for Related Content PubMed Articles by Dam, M. Social Bookmarking                         What's this?

Vigabatrin in Refractory Epilepsy in Adults and Its Application in Children

University Clinic of Neurology, Hvidovre Hospital, Hvidovre, Denmark

Vigabatrin has been studied in adult drug-resistant epilepsy since 1982 in single-blind and double-blind studies followed by long-term, open evaluations. These studies have provided evidence that vigabatrin is a potent and well-tolerated antiepileptic drug and support its potential value in pediatric epilepsy. The lack of any evidence of human neurotoxicity in these patients is also reassuring regarding its use in children. (J Child Neurol 1991;6(Suppl):2525-2529).

Journal of Child Neurology, Vol. 6, No. 2 Suppl, 2S25-2S29 (1991)
DOI: 10.1177/0883073891006002061


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Mumford and O. Dulac Vigabatrin: A New Antiepileptic Medication J Child Neurol, October 1, 1991; 6(2_suppl): 2S3 - 2S6. [PDF]